{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:05:28Z","timestamp":1758121528902},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>The androgen insensitivity syndrome (AIS) is an X\u2010linked form of male pseudohermaphroditism caused by mutations in the androgen receptor (AR) gene. In the present study, we analyzed the AR gene in 8 patients, 4 sporadic and 2 familial cases with the syndrome, using exon\u2010specific polymerase chain reaction, single\u2010stranded conformational polymorphism and sequencing analysis and identified six new single base mutations, including one nonsense mutation at the hinge region of the receptor. These molecular lesions occurred in the steroid\u2010binding domain (SBD) and all but one affected the first nucleotide of their respective codons. A nonsense mutation in exon 4, which converts a glutamine into a premature termination signal (Q657stop), a missense mutation changing arginine instead of glycine (G743R) and a conservative substitution of leucine with valine at amino acid 830 (L830V) were detected in patients with CAIS. Three other missense mutations located in exons 4 (L701I), 5 (A765S), and 6 (Q802R) were present in individuals bearing a partial form of AIS. These data allow us to reaffirm the view that nonsense mutations in the AR results almost invariably in a CAIS phenotype and underly the importance of the SBD for the AR functional activity.<\/jats:p>","DOI":"10.1034\/j.1399-0004.2001.590307.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T11:26:05Z","timestamp":1047381965000},"page":"185-188","source":"Crossref","is-referenced-by-count":10,"title":["Novel molecular defects in the androgen receptor gene of Mexican patients with androgen insensitivity"],"prefix":"10.1111","volume":"59","author":[{"given":"B","family":"Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Vilchis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jc","family":"Zenteno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kofman\u2010Alfaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"2967","volume-title":"The androgen resistance syndromes: steroid 5a\u2010reductase 2 deficiency, testicular feminization, and related disorders","author":"Griffin JE","year":"1995"},{"key":"e_1_2_6_3_2","first-page":"456","article-title":"Androgen resistance due to mutation of the androgen receptor","volume":"15","author":"Pinsky L","year":"1992","journal-title":"Clin Invest Med"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8628(19960503)63:1<218::aid-ajmg38>3.0.co;2-p"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-16-3-271"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050542"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-4-754"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.4.1202"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4289"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.8.2994"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.76.6.529"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.23.9534"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(89)90129-8"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1997.tb02498.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<103::AID-HUMU2>3.0.CO;2-A"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)52466-2"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.187.263"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90316-O"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","unstructured":"Zhao X\u2010Y et al. Androgen insensitivity due to a double mutation in the androgen receptor of a new human prostate cancer cell line MDA PCa 2a. 81st Annual Meeting The Endocrine Society. San Diego CA 1999 Abstract P1\u2013613.","DOI":"10.1016\/S0022-5347(05)68158-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90081-7"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.1.17"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/1.7.497"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)55315-1","article-title":"A unique point mutation in the androgen receptor gene in a family with complete androgen insensitivity syndrome","volume":"58","author":"Sweet CR","year":"1992","journal-title":"Fertil Steril"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00001-0"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70387-7"},{"key":"e_1_2_6_26_2","first-page":"1003","article-title":"Germ\u2010line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling","volume":"60","author":"Boehmer ALM","year":"1997","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.11.3584"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1521-1878(199810)20:10<860::aid-bies12>3.3.co;2-j"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.2.658"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.6.2253"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0004.2001.590307.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0004.2001.590307.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-0004.2001.590307.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:55:01Z","timestamp":1697522101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-0004.2001.590307.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1034\/j.1399-0004.2001.590307.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-0004.2001.590307.x","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}